Cellebrite DI Ltd. CLBT
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Net Income | 6.37M | 21.26M | 20.19M | 19.48M | |
| Total Depreciation and Amortization | 8.92M | 3.94M | 2.70M | 2.59M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 13.26M | 14.31M | 13.04M | 3.92M | |
| Change in Net Operating Assets | -10.96M | 47.30M | -2.66M | 6.60M | |
| Cash from Operations | 17.59M | 86.81M | 33.27M | 32.58M | |
| Capital Expenditure | -3.07M | -3.96M | -3.32M | -3.61M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | 0.00 | -147.46M | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -10.68M | -94.70M | 67.11M | 44.19M | |
| Cash from Investing | -13.75M | -246.11M | 63.79M | 40.58M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 3.61M | 2.34M | 5.27M | 13.83M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 3.61M | 2.34M | 5.27M | 13.83M | |
| Foreign Exchange rate Adjustments | 110.00K | 56.00K | -189.00K | 1.76M | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 7.56M | -156.90M | 102.14M | 88.75M | |